Insider Cluster (2 insiders) ·Filed Sep 10, 2026

UTHR

UNITED THERAPEUTICS Corp
MIXED
Impact 4/10
Horizonweeks Processed21d 7h ago
Insider cluster: 2 insiders, $1.8M total
Actionable Insight ◆ Mixed

The CEO's concentrated selling alongside a large buyback creates a tension: the buyback signals management's view that shares are undervalued, but the CEO's personal selling suggests otherwise. Monitor for any subsequent Form 4 filings from other C-suite executives — if additional insiders sell, the bearish signal strengthens. The ASR's final settlement in Q4 2026 will determine actual share retirement; track VWAP during the term for buyback efficiency.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+5d ⚠ clustered
UTHR ▼ -1.31% at T+5d
NEUTRAL call ✗ call lost -1.31% · α vs SPY -0.81% · entry $503.86 → $497.27
Next anchor: T+20d in 5d
Latest observation: T+14 +6.44% FF3 residual α
Entry anchored
Sep 9, 06:08 PM ET
via 1-min bar
T+1d
-1.34%
call -1.34% · α -2.19%
$497.11
settled 22d ago
T+5d
-1.31%
call -1.31% · α -0.81%
$497.27
settled 16d ago
T+20d
—
call — · α —
—
in 5d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt sold ~$5.9M of UTHR stock over two days (Sep 8-9), including shares acquired via option exercises at $117.76, while EVP & General Counsel Paul Mahon sold $1.13M on Sep 3. The sales coincide with the company's announcement of a $477.6M accelerated share repurchase (ASR) agreement with Citibank on Sep 8. The CEO's large-scale selling alongside a major capital return program creates a mixed signal — the buyback is credit-positive and reduces share count, but insider sales of this magnitude by the top executive warrant caution. At ~0.03% of market cap, the total open-market sales are trivial in proportion, but the CEO's concentrated selling pattern is notable given her insider status and the proximity to the ASR announcement.

Key Financial Metrics

Direction
selling
Total Value
$1.8M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$5.9M in open-market sales over Sep 8-9, including shares from option exercises at $117.76 strike price.
  • EVP & General Counsel Paul Mahon sold $1.13M on Sep 3.
  • Company announced $477.6M accelerated share repurchase (ASR) agreement with Citibank on Sep 8, receiving ~719,376 initial shares.
  • Total open-market insider sales of ~$7.0M represent ~0.03% of UTHR's $21.7B market cap — trivial proportionally.
  • The ASR is expected to settle in Q4 2026, with final share count based on VWAP during the term.

Financial Impact

CEO sold ~$5.9M and GC sold $1.13M in open-market sales; company committed $477.6M to share buyback via ASR

share countcash deploymentinsider ownership

Risk Factors

  • CEO selling may indicate lack of confidence despite buyback announcement
  • ASR final settlement could result in fewer shares repurchased if stock price rises during the term
  • No other C-suite insiders bought shares to offset the selling pattern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1789106552984
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 11, 2026